The US Food and Drug Administration issued a proposal requiring foreign tobacco manufacturers to register their establishments and list the products they sell in the country, a move that bolsters the outlook for Altria Group. The proposed rule would close a regulatory gap that exempted foreign entities from registration and product listing requirements, putting them on par with domestic manufacturers and making it easier to identify illegal foreign tobacco products. Foreign manufacturers would also be required to maintain records of product labeling, advertising, and consumer information. The proposal is part of an effort to strengthen the FDA's ability to identify illegal foreign tobacco products and would lessen competition for Altria, especially from illegal foreign products that have proliferated in the market. Altria is one of the top dividend stocks in the Renaissance Technologies portfolio with a yield of 5.83%.
Altria GroupFDA proposal to require foreign tobacco manufacturers to register and list products, reducing competition from illegal foreign products.